Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2011 | 1 |
2013 | 1 |
2021 | 3 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study.
Retina. 2021 Feb 1;41(2):266-276. doi: 10.1097/IAE.0000000000002862.
Retina. 2021.
PMID: 32496343
Free PMC article.
Calculating the individual probability of successful ocriplasmin treatment in eyes with vitreomacular traction-Validation and refinement of a multivariable prediction model.
Paul C, Müller HH, Raber T, Bertelmann T; EXPORT study group.
Paul C, et al. Among authors: raber t.
PLoS One. 2022 Jul 25;17(7):e0270120. doi: 10.1371/journal.pone.0270120. eCollection 2022.
PLoS One. 2022.
PMID: 35877658
Free PMC article.
Item in Clipboard
Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics.
Bertelmann T, Berndzen L, Raber T, Pfeiffer S, Leha A, Paul C, Feltgen N, Bemme S.
Bertelmann T, et al. Among authors: raber t.
Sci Rep. 2021 Dec 16;11(1):24096. doi: 10.1038/s41598-021-03509-z.
Sci Rep. 2021.
PMID: 34916576
Free PMC article.
Item in Clipboard
Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies.
Joondeph BC, Willems P, Raber T, Duchateau L, Markoff J.
Joondeph BC, et al. Among authors: raber t.
J Ophthalmic Vis Res. 2021 Jan 20;16(1):42-55. doi: 10.18502/jovr.v16i1.8250. eCollection 2021 Jan-Mar.
J Ophthalmic Vis Res. 2021.
PMID: 33520127
Free PMC article.
Item in Clipboard
Determination of the trypanocidal drug melarsoprol and its conversion products in biological fluids with HPLC-ICPMS/ESMS.
Raber G, Raber T, Raml R, Murko M, Magnes C, Francesconi KA.
Raber G, et al. Among authors: raber t.
Talanta. 2013 Nov 15;116:876-81. doi: 10.1016/j.talanta.2013.07.066. Epub 2013 Aug 7.
Talanta. 2013.
PMID: 24148488
Item in Clipboard
Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice.
Lanzl I, Raber T.
Lanzl I, et al. Among authors: raber t.
Clin Ophthalmol. 2011;5:291-8. doi: 10.2147/OPTH.S16355. Epub 2011 Mar 2.
Clin Ophthalmol. 2011.
PMID: 21468336
Free PMC article.
Item in Clipboard
Observational study results in glaucoma patients undergoing a regimen replacement to fixed combination travoprost 0.004%/timolol 0.5% in Germany.
Arend KO, Raber T.
Arend KO, et al. Among authors: raber t.
J Ocul Pharmacol Ther. 2008 Aug;24(4):414-20. doi: 10.1089/jop.2007.0123.
J Ocul Pharmacol Ther. 2008.
PMID: 18665813
Item in Clipboard
Cite
Cite